ArticleFrontiers in radiology2025
Effective deep convolutional neural network with attention mechanism for Alzheimer disease classification.
Article in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The reports from the Health Organizations indicates a sudden growth in neurocognitive disorders among middle-aged and elderly individuals. The accurate detection of Alzheimer's disease (AD) is essential for improving patient care, specifically during the early stages, where timely risk identification enables individuals to adopt preventive measures before irreversible brain damage occurs. Though, several studies have discovered about computerized approaches for AD, many existing techniques remain limited by inherent methodological constraints and insufficient clinical scrutiny. The current systems struggle to reliably predict the disorder in its initial stages. To reduce the need for frequent clinical visit and lower diagnostic costs, the machine learning and deep learning have emerged as powerful tools for AD detection. Methods: This work reviews several research relevant on studies on AD and highlights how these computational techniques can support researchers in achieving more efficient and accurate early-stage detection. The Deep Convolutional Neural Network (Deep-CNN) with Attention mechanism is proposed to augment the spatial attention module and multi-class classification of Alzheimer disease stages. The model has trained and evaluated on the OASIS dataset using subject-level which satisfy statistical-validation and standard preprocessing. Results: The proposed Deep-CNN and attention model focuses the model capacity on diagnostically relevant regions. The proposed model achieved an accuracy of 97%, which is higher than existing methods like SVM with kernels (90.5%), SVM Gaussian radial basis kernel (85%), and traditional CNN (93.5%). Discussion: The visualizations of attention mechanism are used to increase the interpretability and demonstrate the attention maps which are align with known AD biomarkers. These results indicates that the attention-guided deep models can both improve multi-class MRI classification accuracy and provide clinically useful regional explanations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.